Mainz Biomed Financials
| MYNZ Stock | USD 0.21 0.05 17.69% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.92 | 0.9722 |
|
|
The financial analysis of Mainz Biomed is a critical element in measuring its lifeblood. Investors should not minimize Mainz Biomed's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Net Income |
|
Mainz | Select Account or Indicator |
Understanding current and past Mainz Biomed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Mainz Biomed's financial statements are interrelated, with each one affecting the others. For example, an increase in Mainz Biomed's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Mainz Biomed's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mainz Biomed BV. Check Mainz Biomed's Beneish M Score to see the likelihood of Mainz Biomed's management manipulating its earnings.
Mainz Biomed Stock Summary
Mainz Biomed competes with Electrocore LLC, Evogene, Evolus, and OncoCyte Corp. Mainz Biomed B.V., a molecular genetics cancer diagnostic company, develops in-vitro diagnostic and research use only tests for clinical diagnostics in human genetics. The company was founded in 2008 and is based in Mainz, Germany. Mainz Biomed is traded on NASDAQ Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | NL0015000LC2 |
| CUSIP | N5436L101 |
| Location | Germany |
| Business Address | Robert Koch Strasse |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | mainzbiomed.com |
| Phone | 49 6131 554 2860 |
| Currency | USD - US Dollar |
Mainz Biomed Key Financial Ratios
| Return On Equity | -43.34 | ||||
| Operating Margin | (18.83) % | ||||
| Price To Sales | 17.87 X | ||||
| Revenue | 895.48 K | ||||
| Gross Profit | 177.62 K |
Mainz Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Mainz Biomed's current stock value. Our valuation model uses many indicators to compare Mainz Biomed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mainz Biomed competition to find correlations between indicators driving Mainz Biomed's intrinsic value. More Info.Mainz Biomed BV is regarded fifth in return on equity category among its peers. It also is regarded fifth in return on asset category among its peers . At this time, Mainz Biomed's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mainz Biomed's earnings, one of the primary drivers of an investment's value.Mainz Biomed BV Systematic Risk
Mainz Biomed's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mainz Biomed volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Mainz Biomed BV correlated with the market. If Beta is less than 0 Mainz Biomed generally moves in the opposite direction as compared to the market. If Mainz Biomed Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mainz Biomed BV is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mainz Biomed is generally in the same direction as the market. If Beta > 1 Mainz Biomed moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Mainz Biomed Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mainz Biomed's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Mainz Biomed growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Mainz Biomed November 29, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Mainz Biomed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mainz Biomed BV. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mainz Biomed BV based on widely used predictive technical indicators. In general, we focus on analyzing Mainz Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mainz Biomed's daily price indicators and compare them against related drivers.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 46.82 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 13.04 |
Additional Tools for Mainz Stock Analysis
When running Mainz Biomed's price analysis, check to measure Mainz Biomed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mainz Biomed is operating at the current time. Most of Mainz Biomed's value examination focuses on studying past and present price action to predict the probability of Mainz Biomed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mainz Biomed's price. Additionally, you may evaluate how the addition of Mainz Biomed to your portfolios can decrease your overall portfolio volatility.